hackint0sh/temp-data huggingface dataset:
protocolSection identificationModule nctId: NCT06303219, orgStudyIdInfo id: REC/RCR&AHS/23/0577, briefTitle: Effects of Traditional Moderate Intensity Training and High Intensity Interval Training in Polycystic Ovarian Syndrome, statusModule overallStatus: RECRUITING, startDateStruct date: 2023-11-23, primaryCompletionDateStruct date: 2024-08-01, completionDateStruct date: 2024-09-01, studyFirstPostDateStruct date: 2024-03-12, lastUpdatePostDateStruct date: 2024-03-12, sponsorCollaboratorsModule leadSponsor name: Riphah International University, class: OTHER, descriptionModule briefSummary: To determine the comparative effects of traditional moderate intensity training and high intensity interval training on Anxiety, fatigue and Quality of Life in females with polycystic ovarian syndrome, conditionsModule conditions: Polycystic Ovarian Syndrome, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: SINGLE, whoMasked: PARTICIPANT, enrollmentInfo count: 44, type: ESTIMATED, armsInterventionsModule interventions name: RADITIONAL MODERATE INTENSITY TRAINING, interventions name: HIGH INTENSITY INTERVAL TRAINING, outcomesModule primaryOutcomes measure: Hamilton Anxiety Rating scale (HAM-A), primaryOutcomes measure: The Polycystic Ovary Syndrome Health-Related Quality of Life Questionnaire (PCOSQ), primaryOutcomes measure: The Fatigue Impact Scale (FIS), eligibilityModule sex: FEMALE, minimumAge: 18 Years, maximumAge: 35 Years, stdAges: ADULT, contactsLocationsModule locations facility: Gynecological Department of Fatima Memorial Hospital, status: RECRUITING, city: Lahore, zip: 05499, country: Pakistan, contacts name: hina gul gul, role: CONTACT, phone: 03214979172, email: hina.gul@riphah.edu.pk, contacts name: Fatima Kashif, MSPT(WH), role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 31.558, lon: 74.35071, hasResults: False
protocolSection identificationModule nctId: NCT06303206, orgStudyIdInfo id: H23-00623, briefTitle: TEC4Home Blood Pressure Randomized Controlled Trial, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-06-01, primaryCompletionDateStruct date: 2027-01-01, completionDateStruct date: 2027-01-01, studyFirstPostDateStruct date: 2024-03-12, lastUpdatePostDateStruct date: 2024-03-12, sponsorCollaboratorsModule leadSponsor name: University of British Columbia, class: OTHER, descriptionModule briefSummary: The goal of this clinical trial is to evaluate the effect of home blood pressure telemonitoring (HBPT) and case management (CM), relative to usual care, for improving blood pressure (BP) control among patients with high blood pressure discharged from the emergency department (ED).The main question it aims to answer is: Does telemonitoring with case management improve BP control, relative to usual care, for people with high blood pressure discharged from the ED?Secondary research questions will address:1. How do these interventions (telemonitoring and case management) improve medication adherence?2. Do these interventions reduce physician and ED visits?3. Are these interventions safe?4. How do these interventions influence patient experience?Participants in the intervention group will receive training and use of a home BP telemonitor with tele-transmission function for 12-months plus pharmacist case management to provide behavioral counseling, facilitate medication adherence, review telemonitored BP data, and adjust medications. The control group will receive usual care from their primary care physician and will receive the same home BP monitor and hypertension education., conditionsModule conditions: Hypertension, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 408, type: ESTIMATED, armsInterventionsModule interventions name: Home Blood Pressure Telemonitoring (HBPT) + Case Management (CM), outcomesModule primaryOutcomes measure: Systolic blood pressure controlled, secondaryOutcomes measure: Impact of intervention on other blood pressure measures, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule, hasResults: False
protocolSection identificationModule nctId: NCT06303167, orgStudyIdInfo id: NCI-2024-01150, secondaryIdInfos id: NCI-2024-01150, type: REGISTRY, domain: CTRP (Clinical Trial Reporting Program), secondaryIdInfos id: EAY131-E, type: OTHER, domain: ECOG-ACRIN Cancer Research Group, secondaryIdInfos id: EAY131-E, type: OTHER, domain: CTEP, secondaryIdInfos id: U10CA180820, type: NIH, link: https://reporter.nih.gov/quickSearch/U10CA180820, briefTitle: Testing AZD9291 as Potentially Targeted Treatment in Cancers With EGFR Genetic Changes (MATCH-Subprotocol E), statusModule overallStatus: ACTIVE_NOT_RECRUITING, startDateStruct date: 2015-08-06, primaryCompletionDateStruct date: 2024-05-26, completionDateStruct date: 2024-05-26, studyFirstPostDateStruct date: 2024-03-12, lastUpdatePostDateStruct date: 2024-03-12, sponsorCollaboratorsModule leadSponsor name: National Cancer Institute (NCI), class: NIH, descriptionModule briefSummary: This phase II MATCH treatment trial evaluates the effectiveness of osimertinib (AZD9291) in treating patients with cancer that has certain genetic changes called EGFR mutations. Osimertinib is in a class of medications called kinase inhibitors. It works by blocking the action of mutant forms of the EGFR protein, which play a key role in tumor cell growth. Osimertinib may cause tumor cell death and inhibit tumor growth in EGFR-overexpressing tumor cells, thereby stopping or slowing the spread of tumor cells., conditionsModule conditions: Advanced Lymphoma, conditions: Advanced Malignant Solid Neoplasm, conditions: Hematopoietic and Lymphoid Cell Neoplasm, conditions: Refractory Lymphoma, conditions: Refractory Malignant Solid Neoplasm, conditions: Refractory Multiple Myeloma, designModule studyType: INTERVENTIONAL, phases: PHASE2, designInfo allocation: NA, interventionModel: SINGLE_GROUP, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 35, type: ESTIMATED, armsInterventionsModule interventions name: Biopsy, interventions name: Biospecimen Collection, interventions name: Echocardiography, interventions name: Multigated Acquisition Scan, interventions name: Osimertinib, interventions name: Radiologic Examination, outcomesModule primaryOutcomes measure: Objective response rate, secondaryOutcomes measure: Overall survival, secondaryOutcomes measure: Progression free survival, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule, hasResults: False
protocolSection identificationModule nctId: NCT06303154, orgStudyIdInfo id: EC45 MOBIBRA, secondaryIdInfos id: ID-RCB, type: OTHER, domain: 2023-A01937-38, briefTitle: Evaluation of Mobiderm Intimate Bra in the Management of Breast Edema Related to Breast Cancer Treatment, acronym: MOBIBRA, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-03-21, primaryCompletionDateStruct date: 2025-09, completionDateStruct date: 2025-09, studyFirstPostDateStruct date: 2024-03-12, lastUpdatePostDateStruct date: 2024-04-16, sponsorCollaboratorsModule leadSponsor name: Thuasne, class: INDUSTRY, descriptionModule briefSummary: The aim of this exploratory study is to assess the performance and tolerability of the MOBIDERM Intimate Bra in the management of breast edema related to breast cancer treatment., conditionsModule conditions: Breast Cancer Surgery, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: NA, interventionModel: SINGLE_GROUP, interventionModelDescription: Prospective, exploratory, monocentric, uncontrolled clinical study., primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 30, type: ESTIMATED, armsInterventionsModule interventions name: Mobiderm Intimate Bra group, outcomesModule primaryOutcomes measure: Evolution of breast edema severity, secondaryOutcomes measure: Comparison of methods to follow changes in the severity of breast edema - TDC measurement, secondaryOutcomes measure: Comparison of methods to follow changes in the severity of breast edema - Clinical assessment, secondaryOutcomes measure: Comparison of methods to follow changes in the severity of breast edema - Ultrasound measurement, secondaryOutcomes measure: Time to edema onset, secondaryOutcomes measure: Time to edema disappearance, secondaryOutcomes measure: Symptoms and quality of life changes associated with breast edema, secondaryOutcomes measure: Breast edema hypersensitivity, secondaryOutcomes measure: Breast pain, secondaryOutcomes measure: Skin changes associated with breast edema, secondaryOutcomes measure: Physical activity, secondaryOutcomes measure: Healing time, secondaryOutcomes measure: Safety of the device, secondaryOutcomes measure: Compliance to the device, secondaryOutcomes measure: Patient's satisfaction, eligibilityModule sex: FEMALE, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Groupe Hospitalier Paris Saint Joseph - Groupement FEHAP, status: RECRUITING, city: Paris, state: Paris 14, zip: 75014, country: France, contacts name: Séverine ALRAN, Dr, role: CONTACT, geoPoint lat: 48.85341, lon: 2.3488, hasResults: False
protocolSection identificationModule nctId: NCT06303141, orgStudyIdInfo id: LUC/CPGS/PGS/20230405/001, briefTitle: Comparative Effects of Neuromuscular Training and Mobilization With Movement in Professional Athletes With Ankle Sprain, statusModule overallStatus: COMPLETED, startDateStruct date: 2023-04-05, primaryCompletionDateStruct date: 2023-09-05, completionDateStruct date: 2023-09-10, studyFirstPostDateStruct date: 2024-03-12, lastUpdatePostDateStruct date: 2024-03-12, sponsorCollaboratorsModule leadSponsor name: Riphah International University, class: OTHER, descriptionModule briefSummary: The study aims to compare the effects of neuromuscular training and mobilization with movement on pain, range of motion, function, and disability in professional athletes with ankle sprain. Neuromuscular training focuses on improving neuromuscular control and stability, while mobilization with movement aims to restore joint mobility and function. By investigating the outcomes of these two interventions, the study seeks to provide insights into their effectiveness for managing ankle sprains in professional athletes., conditionsModule conditions: Ankle Injuries, conditions: Musculoskeletal Manipulations, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: SINGLE, maskingDescription: the assessor who take the reading is blind, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 60, type: ACTUAL, armsInterventionsModule interventions name: Closed Chain exercises, interventions name: Neuromuscular Training, interventions name: Mobilization with Movement, outcomesModule primaryOutcomes measure: Numerical Pain Rating Scale for Pain, primaryOutcomes measure: Goniometer for Range of Motion, primaryOutcomes measure: Star balance excursion test for Balance, primaryOutcomes measure: Foot and ankle ability Measure for Functional Performance, primaryOutcomes measure: Cumberland Ankle Instability, secondaryOutcomes measure: Agility T-test, secondaryOutcomes measure: Speed (20m sprint test), eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 30 Years, stdAges: ADULT, contactsLocationsModule locations facility: Pakistan Sports Board, city: Lahore, state: Punjab, country: Pakistan, geoPoint lat: 31.558, lon: 74.35071, hasResults: False
protocolSection identificationModule nctId: NCT06303089, orgStudyIdInfo id: zzwee-quit (CKD) 23152, briefTitle: Tobacco Exposure and Influencing Factors of Smoking Cessation Among Chronic Kidney Disease Patients, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-04-01, primaryCompletionDateStruct date: 2025-01-01, completionDateStruct date: 2025-03-01, studyFirstPostDateStruct date: 2024-03-12, lastUpdatePostDateStruct date: 2024-03-12, sponsorCollaboratorsModule leadSponsor name: Sun Yat-sen University, class: OTHER, descriptionModule briefSummary: The purpose of this study is to describe the tobacco exposure and characteristics of patients with Chronic Kidney Disease (CKD) who quit smoking, to identify patients' tobacco-related knowledge, attitude, and practice (KAP) and explore the influencing factors of smoking cessation., conditionsModule conditions: Smoking Cessation, designModule studyType: OBSERVATIONAL, designInfo observationalModel: OTHER, timePerspective: CROSS_SECTIONAL, enrollmentInfo count: 554, type: ESTIMATED, armsInterventionsModule interventions name: Questionnaires set, outcomesModule primaryOutcomes measure: Prevalence of current smokers, primaryOutcomes measure: Abstinence rates, secondaryOutcomes measure: Nicotine dependence, secondaryOutcomes measure: Perceptions of tobacco harm, secondaryOutcomes measure: knowledge of tobacco-related diseases, secondaryOutcomes measure: Smoking related attitudes, secondaryOutcomes measure: Self-efficacy level, secondaryOutcomes measure: Withdrawal symptoms, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: XIAW, city: Guangzhou, state: Guangdong, zip: 510080, country: China, contacts name: Wei Xia, PhD, role: CONTACT, phone: 18823359471, email: xiaw23@mail.sysu.edu.cn, geoPoint lat: 23.11667, lon: 113.25, hasResults: False
protocolSection identificationModule nctId: NCT06303063, orgStudyIdInfo id: SNSC-IAS-202301, briefTitle: Compare the Safety and Effectiveness of Two Different Kinds of Stent System in Intracranial Aneurysms, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-01-17, primaryCompletionDateStruct date: 2025-06-30, completionDateStruct date: 2025-12-30, studyFirstPostDateStruct date: 2024-03-12, lastUpdatePostDateStruct date: 2024-04-01, sponsorCollaboratorsModule leadSponsor name: Sinomed Neurovita Technology Inc., class: INDUSTRY, descriptionModule briefSummary: The primary objective of this trial is to evaluate the safety and efficacy of SINOMED IAS in patients with intracranial aneurysms., conditionsModule conditions: Intracranial Aneurysm, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: SINGLE, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 204, type: ESTIMATED, armsInterventionsModule interventions name: SINOMED IAS Stent System, interventions name: Neuroform Atlas Stent System, outcomesModule primaryOutcomes measure: Success aneurysm occlusion at 6 month post procedure, secondaryOutcomes measure: Technical success, secondaryOutcomes measure: Success aneurysm occlusion immediately after the procedure, secondaryOutcomes measure: Complete aneurysm occlusion without significant parent artery stenosis (≤50%) or retreatment at 6 months post procedure, secondaryOutcomes measure: Complete aneurysm occlusion at 6 months post procedure, secondaryOutcomes measure: Retreatment Rate at 6 months and 1 year post procedure, secondaryOutcomes measure: In-Stent Stenosis at 6 months post procedure, secondaryOutcomes measure: Modified Rankin Scale (mRS) at 30 days, 6 months and 1 year post procedure, secondaryOutcomes measure: Major ipsilateral stroke at 30 days, 6 months and 1 year post procedure, secondaryOutcomes measure: All-cause mortality at 30 days, 6 months and 1 year post procedure, secondaryOutcomes measure: Incidence of adverse events/serious adverse events during 30 days, 6 months and 1 year post procedure, secondaryOutcomes measure: In-stent thrombosis at 6 months post procedure, secondaryOutcomes measure: Rate of Device defect, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 80 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Beijing Tiantan Hospital, Capital Medical University, status: RECRUITING, city: Beijing, country: China, contacts name: Jianxin Yang, role: CONTACT, phone: 010-59978595, email: yangxinjian@voiceoftiantan.org, geoPoint lat: 39.9075, lon: 116.39723, hasResults: False
protocolSection identificationModule nctId: NCT06303050, orgStudyIdInfo id: Urooj Amir, briefTitle: Additional Effects of Mental Imagery Along With Task Oriented Training on Kinesiophobia in Patients With Stroke, statusModule overallStatus: RECRUITING, startDateStruct date: 2023-12-07, primaryCompletionDateStruct date: 2024-06-07, completionDateStruct date: 2024-06-07, studyFirstPostDateStruct date: 2024-03-12, lastUpdatePostDateStruct date: 2024-03-12, sponsorCollaboratorsModule leadSponsor name: Riphah International University, class: OTHER, descriptionModule briefSummary: The objective of this study to determine the effect of mental imagery and task oriented training on Kinesiophobia in stroke patients. And to determine the association of Kinesiophobia with gait and balance in stroke patients. Patients will be divided into experimental and control group. Randomized participants will be allocated into control and experimental group. The experimental group will receive 20 minutes of MI training followed by 25 minutes of TOT for a total of 45 minutes, 5 days per week for 6 weeks., conditionsModule conditions: Stroke, Cardiovascular, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: DOUBLE, whoMasked: PARTICIPANT, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 44, type: ESTIMATED, armsInterventionsModule interventions name: Mental Imagery with task Oriented training group, interventions name: Task Oriented training group, outcomesModule primaryOutcomes measure: Berg And Balance scale, primaryOutcomes measure: Tempa scale for kinesiophobia, primaryOutcomes measure: Ten-meter walk test, primaryOutcomes measure: Dynamic gate index, primaryOutcomes measure: Time Up and Go Test, eligibilityModule sex: ALL, minimumAge: 45 Years, maximumAge: 60 Years, stdAges: ADULT, contactsLocationsModule locations facility: Khyber Medical University, status: RECRUITING, city: Peshawar, state: KPK, zip: 2500, country: Pakistan, contacts name: Nadia Azhar, NMPT, role: CONTACT, phone: 03335281431, email: nadia.azhar@riphah.edu.pk, geoPoint lat: 34.008, lon: 71.57849, hasResults: False
protocolSection identificationModule nctId: NCT06303037, orgStudyIdInfo id: SAHoWMU-CR2024-03-105, briefTitle: Effect of Esketamine on 95% Induction Dose of Remimazolam, acronym: EEIDR, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-04, primaryCompletionDateStruct date: 2025-02, completionDateStruct date: 2025-03, studyFirstPostDateStruct date: 2024-03-12, lastUpdatePostDateStruct date: 2024-03-12, sponsorCollaboratorsModule leadSponsor name: Second Affiliated Hospital of Wenzhou Medical University, class: OTHER, descriptionModule briefSummary: As an invasive operation, gastroscopy will cause children's nervousness, anxiety and uncooperative behavior, and even lead to the risk of bleeding and perforation, which will also affect the accuracy of the examination results.The purpose of this study is to explore the influence of different doses of esketamine on the induced dose ED95 of remazolam during gastroscopic placement in children, and to provide theoretical basis for the combined use of remimazolam besylate and esketamine in gastroscopic anesthesia in children., conditionsModule conditions: Pediatric, conditions: Gastroscopy, conditions: ED95, conditions: Sedation, designModule studyType: INTERVENTIONAL, phases: PHASE4, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: TRIPLE, whoMasked: PARTICIPANT, whoMasked: INVESTIGATOR, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 80, type: ESTIMATED, armsInterventionsModule interventions name: Remimazolam besylate and low-dose Esketamine, interventions name: Remimazolam besylate and Medium dose Esketamine, outcomesModule primaryOutcomes measure: Sedation induction time, secondaryOutcomes measure: Modified observer's assessment of alertness#sedation#MOAA/S#scale, secondaryOutcomes measure: Recovery times, secondaryOutcomes measure: VAS(The difficulty of gastroscope insertion), secondaryOutcomes measure: Number of children with adverse effects, eligibilityModule sex: ALL, minimumAge: 3 Years, maximumAge: 12 Years, stdAges: CHILD, contactsLocationsModule locations facility: The second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, city: Wenzhou, state: Zhejiang, country: China, geoPoint lat: 27.99942, lon: 120.66682, hasResults: False
protocolSection identificationModule nctId: NCT06303011, orgStudyIdInfo id: S22C14G92003, briefTitle: Abdominal Massage With TENS on Parasacral Versus Sacral Area on Symptom,Severity & QOL in Chronic Constipation Females., statusModule overallStatus: COMPLETED, startDateStruct date: 2023-03-15, primaryCompletionDateStruct date: 2024-03-15, completionDateStruct date: 2024-03-15, studyFirstPostDateStruct date: 2024-03-12, lastUpdatePostDateStruct date: 2024-04-22, sponsorCollaboratorsModule leadSponsor name: Riphah International University, class: OTHER, descriptionModule briefSummary: Constipation is Infrequent or difficult evacuation of FECES. These symptoms are associated with a variety of causes, including low DIETARY FIBER intake, emotional or nervous disturbances, systemic and structural disorders, drug-induced aggravation, and infections. Patients complaining of constipation may mean different things by the term The frequency of their bowel actions may be less than 'normal', their stools maybe difficult to pass, or they may have a sense of malaise or abdominal discomfort which they attribute to a 'sluggish bowel', though the stool frequency and consistency are apparently normal. Objective of this study is to compare effects of Abdominal massage. withTENSonparasacralversussacralareaonsymptomseverityandqualityoflifein severechronicconstipationamongyoungfemales., conditionsModule conditions: Constipation, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 26, type: ACTUAL, armsInterventionsModule interventions name: Transcutaneous Electrical Nerve Stimulator, interventions name: TENS on para sacral area with Abdominal Massage, outcomesModule primaryOutcomes measure: PAC-SYM Questionnaire, primaryOutcomes measure: PAC-QOL Questionnaire, eligibilityModule sex: FEMALE, minimumAge: 14 Years, maximumAge: 35 Years, stdAges: CHILD, stdAges: ADULT, contactsLocationsModule locations facility: Jinnah Hospital, city: Lahore, state: Punjab, zip: 44000, country: Pakistan, geoPoint lat: 31.558, lon: 74.35071, hasResults: False